1. Home
  2. IBN vs BSX Comparison

IBN vs BSX Comparison

Compare IBN & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBN
  • BSX
  • Stock Information
  • Founded
  • IBN 1955
  • BSX 1979
  • Country
  • IBN India
  • BSX United States
  • Employees
  • IBN N/A
  • BSX N/A
  • Industry
  • IBN Commercial Banks
  • BSX Medical/Dental Instruments
  • Sector
  • IBN Finance
  • BSX Health Care
  • Exchange
  • IBN Nasdaq
  • BSX Nasdaq
  • Market Cap
  • IBN 119.5B
  • BSX 138.4B
  • IPO Year
  • IBN 1999
  • BSX 1992
  • Fundamental
  • Price
  • IBN $33.20
  • BSX $104.33
  • Analyst Decision
  • IBN
  • BSX Strong Buy
  • Analyst Count
  • IBN 0
  • BSX 22
  • Target Price
  • IBN N/A
  • BSX $112.86
  • AVG Volume (30 Days)
  • IBN 4.1M
  • BSX 7.3M
  • Earning Date
  • IBN 07-28-2025
  • BSX 07-23-2025
  • Dividend Yield
  • IBN 0.61%
  • BSX N/A
  • EPS Growth
  • IBN 14.82
  • BSX 15.23
  • EPS
  • IBN 0.83
  • BSX 1.37
  • Revenue
  • IBN $23,482,887,936.00
  • BSX $17,554,000,000.00
  • Revenue This Year
  • IBN N/A
  • BSX $17.50
  • Revenue Next Year
  • IBN $14.57
  • BSX $10.75
  • P/E Ratio
  • IBN $19.82
  • BSX $76.14
  • Revenue Growth
  • IBN 40.52
  • BSX 19.36
  • 52 Week Low
  • IBN $27.26
  • BSX $71.88
  • 52 Week High
  • IBN $34.50
  • BSX $107.53
  • Technical
  • Relative Strength Index (RSI)
  • IBN 45.89
  • BSX 53.99
  • Support Level
  • IBN $33.04
  • BSX $101.56
  • Resistance Level
  • IBN $33.80
  • BSX $104.41
  • Average True Range (ATR)
  • IBN 0.27
  • BSX 1.92
  • MACD
  • IBN -0.01
  • BSX -0.05
  • Stochastic Oscillator
  • IBN 30.49
  • BSX 46.40

About IBN ICICI Bank Limited

ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, Other Banking Business, and Others. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs. Geographical segments include Domestic operations and Foreign operations. The company generates the majority of its revenue from the domestic operations.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Share on Social Networks: